Sinoway Industrial Co., Ltd.

Bortezomib Intermediates Bortezomib Intermediates

Bortezomib Intermediates
Related Products
  • Mupirocin 12650-69-0

    Details of MupirocinOther Names: mupirocinMF: C26H44O9Place of Origin: Fujian, China (Mainland)Type: Auxiliaries and Other Medicinal Chemicals, Immune Function AgentsGrade Standard: Medicine GradeBran...

  • Atracurium Besylate 64228-81-5

    Basic information of Atracurium besylate:NameAtracurium besylateAliasCAS NO.64228-81-5 Molecular FormulaC65H82N2O18S2Molecular Weight1243.48Quality StandardCurrent USPPackage Size2kg or 3kg/tin/carton...

  • Ceftiofur Sodium 104010-37-9

    Basic information of Ceftiofur sodium:NameCeftiofur sodiumCAS :104010-37-9Molecular FormulaC19H16N5NaO7S3Molecular Weight545.54Quality StandardPackage SizeFor small quantity:Double plastic bag inside ...

Basic Information of Bortezomib Intermediates

  • CAS No. of key intermediates:179324-87-9
  • Other Names: (R)-BoroLeu-(+)-Pinanediol-CF3COOH
  • MF: C15H28BNO2.C2HF3O2
  • Purity:99.0%min
  • Appearance: White crystalline powder, White crystalline powder
  • Item:cas no.179324-87-9 & other Bortezomib intermediates
  • Shelf life: 2 years

Usage of Bortezomib Intermediates

  • As intermediate of Bortezomib.
  • Bortezomib  is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.
  • Bortezomib is associated with peripheral neuropathy in 30% of patients; occasionally, it can be painful. This can be worse in patients with pre-existing neuropathy. In addition, myelosuppression causing neutropenia and thrombocytopenia can also occur and be dose-limiting. However, these side effects are usually mild relative to bone marrow transplantation and other treatment options for patients with advanced disease. Bortezomib is associated with a high rate of shingles, although prophylactic acyclovir can reduce the risk of this. Acute interstitial nephritis has also been reported.
  • Gastro-intestinal (GI) effects and asthenia are the most common adverse events.

COA of Bortezomib Intermediates

(R)-Boroleu-(+)-pinanediolCF3COOH

Product name

(R)-Boroleu-(+)-pinanediolCF3COOH

CAS No.

179324-87-9

Molecular weight

379.23

Molecular Formula

C15H28BNO2.C2HF3O2

Appearance

white crystalline powder

Assay

99%min.


MORE_DETAIL Bortezomib Intermediates

Basic Information of Bortezomib Intermediates

  • CAS No. of key intermediates:179324-87-9
  • Other Names: (R)-BoroLeu-(+)-Pinanediol-CF3COOH
  • MF: C15H28BNO2.C2HF3O2
  • Purity:99.0%min
  • Appearance: White crystalline powder, White crystalline powder
  • Item:cas no.179324-87-9 & other Bortezomib intermediates
  • Shelf life: 2 years

Usage of Bortezomib Intermediates

  • As intermediate of Bortezomib.
  • Bortezomib  is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.
  • Bortezomib is associated with peripheral neuropathy in 30% of patients; occasionally, it can be painful. This can be worse in patients with pre-existing neuropathy. In addition, myelosuppression causing neutropenia and thrombocytopenia can also occur and be dose-limiting. However, these side effects are usually mild relative to bone marrow transplantation and other treatment options for patients with advanced disease. Bortezomib is associated with a high rate of shingles, although prophylactic acyclovir can reduce the risk of this. Acute interstitial nephritis has also been reported.
  • Gastro-intestinal (GI) effects and asthenia are the most common adverse events.

COA of Bortezomib Intermediates

(R)-Boroleu-(+)-pinanediolCF3COOH

Product name

(R)-Boroleu-(+)-pinanediolCF3COOH

CAS No.

179324-87-9

Molecular weight

379.23

Molecular Formula

C15H28BNO2.C2HF3O2

Appearance

white crystalline powder

Assay

99%min.

Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//